Cargando…
1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease
[Image: see text] α-Glucosidase inhibitors are potential therapeutics for the treatment of diabetes, viral infections, and Pompe disease. Herein, we report a 1,6-epi-cyclophellitol cyclosulfamidate as a new class of reversible α-glucosidase inhibitors that displays enzyme inhibitory activity by virt...
Autores principales: | Kok, Ken, Kuo, Chi-Lin, Katzy, Rebecca E., Lelieveld, Lindsey T., Wu, Liang, Roig-Zamboni, Véronique, van der Marel, Gijsbert A., Codée, Jeroen D. C., Sulzenbacher, Gerlind, Davies, Gideon J., Overkleeft, Herman S., Aerts, Johannes M. F. G., Artola, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389588/ https://www.ncbi.nlm.nih.gov/pubmed/35917590 http://dx.doi.org/10.1021/jacs.2c05666 |
Ejemplares similares
-
Functionalized
Cyclophellitols Are Selective Glucocerebrosidase
Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish
por: Artola, Marta, et al.
Publicado: (2019) -
Carba-cyclophellitols
Are Neutral Retaining-Glucosidase
Inhibitors
por: Beenakker, Thomas J. M., et al.
Publicado: (2017) -
An Orthogonally Protected Cyclitol for the Construction
of Nigerose- and Dextran-Mimetic Cyclophellitols
por: Ofman, Tim P., et al.
Publicado: (2021) -
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
por: Roig-Zamboni, Véronique, et al.
Publicado: (2017) -
Xylose‐Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase
por: Su, Qin, et al.
Publicado: (2021)